{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:23:23Z","timestamp":1790007803289,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier","isbn-type":[{"value":"9780128048245","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.vh.2015.11.002","type":"book-chapter","created":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T13:46:05Z","timestamp":1451742365000},"page":"151-164","source":"Crossref","is-referenced-by-count":13,"title":["Analogs of 1\u03b1,25-Dihydroxyvitamin D3 in Clinical Use"],"prefix":"10.1016","author":[{"given":"Hector F.","family":"DeLuca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2015.11.002_bb0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/ajkd.1998.v32.pm9708607","article-title":"Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism","volume":"32","author":"Akiba","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/bs.vh.2015.11.002_bb0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.6979782","article-title":"24-Hydroxylation of 25-hydroxyvitamin D3: Is it required for embryonic development in chicks?","volume":"217","author":"Ameenuddin","year":"1982","journal-title":"Science"},{"key":"10.1016\/bs.vh.2015.11.002_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2015.11.002_bb0020","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/jo00366a004","article-title":"Stereocontrolled total synthesis of 1\u03b1,25-dihydroxycholecalciferol and 1\u03b1,25-dihydroxyergocalciferol","volume":"51","author":"Baggiolini","year":"1986","journal-title":"Journal of Organic Chemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1525-139X.2002.00086.x","article-title":"Comparative review of the pharmacokinetics of vitamin D analogues","volume":"15","author":"Bailie","year":"2002","journal-title":"Seminars in Dialysis"},{"key":"10.1016\/bs.vh.2015.11.002_bb0030","first-page":"1489","article-title":"Development of new vitamin D analogs","volume":"Vol. 2","author":"Binderup","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/bi00830a031","article-title":"The synthesis of 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3","volume":"8","author":"Blunt","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0040","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/bi00850a001","article-title":"25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3","volume":"7","author":"Blunt","year":"1968","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/edrv-6-4-491","article-title":"Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3","volume":"6","author":"Brommage","year":"1985","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.vh.2015.11.002_bb0050","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/S0040-4020(01)86903-9","article-title":"Synthesis of MC 903 a biologically active vitamin D analogue","volume":"43","author":"Calverley","year":"1987","journal-title":"Tetrahedron"},{"key":"10.1016\/bs.vh.2015.11.002_bb0055","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1053\/ajkd.2002.36899","article-title":"Differential effects of acute administration of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on serum calcium and phosphorus in hemodialysis patients","volume":"40","author":"Coyne","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/bs.vh.2015.11.002_bb9000","first-page":"1101","article-title":"Vitamin D and osteoporosis","volume":"Vol. 2","author":"Eastell","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0003-2697(77)90648-0","article-title":"Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography","volume":"80","author":"Eisman","year":"1977","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0070","volume":"Vols. 1&2","author":"Feldman","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0075","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxyvitamin D3 and 19-nor-1,25-dihydroxyvitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.vh.2015.11.002_bb0080","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197310182891601","article-title":"Pathogenesis of hereditary vitamin D dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1\u03b1,25-dihydroxyvitamin D","volume":"289","author":"Fraser","year":"1973","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2015.11.002_bb0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2000.16193","article-title":"Intermittent doxercalciferol (1alpha-hydroxyvitamin D2) therapy for secondary hyperparathyroidism","volume":"36","author":"Frazao","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/bs.vh.2015.11.002_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0003-9861(71)90320-1","article-title":"1,25-Dihydroxycholecalciferol: The metabolite of vitamin D responsible for increased intestinal calcium transport","volume":"147","author":"Frolik","year":"1971","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0100","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1172\/JCI107114","article-title":"Metabolism of 1,25-dihydroxycholecalciferol in the rat","volume":"51","author":"Frolik","year":"1972","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2015.11.002_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI107214","article-title":"The stimulation of 1,25-dihydroxycholecalciferol metabolism in vitamin D-deficient rats by 1,25-dihydroxycholecalciferol treatment","volume":"52","author":"Frolik","year":"1973","journal-title":"Journal of Clinical Investigation"},{"issue":"4 Suppl. 1","key":"10.1016\/bs.vh.2015.11.002_bb9005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0026-0495(90)90268-H","article-title":"Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis","volume":"39","author":"Gallagher","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/bs.vh.2015.11.002_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650090504","article-title":"Effects of increasing doses of 1\u03b1-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women","volume":"9","author":"Gallagher","year":"1994","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.vh.2015.11.002_bb0110","article-title":"Long term evaluation of the safety of 1\u03b1OHD2 in post-menopausal women. In Journal of Bone and Mineral Research","author":"Gallagher","year":"1993"},{"key":"10.1016\/bs.vh.2015.11.002_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1016\/bs.vh.2015.11.002_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0003-9861(75)90365-3","article-title":"Biological activity of 1\u03b1-hydroxyvitamin D3 in the rat","volume":"166","author":"Holick","year":"1975","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1073\/pnas.68.4.803","article-title":"Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine","volume":"68","author":"Holick","year":"1971","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2015.11.002_bb0130","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1021\/bi00790a023","article-title":"Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine","volume":"10","author":"Holick","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.180.4082.190","article-title":"1\u03b1-Hydroxy derivative of vitamin D3. A highly potent analog of 1\u03b1,25-dihydroxyvitamin D3","volume":"180","author":"Holick","year":"1973","journal-title":"Science"},{"key":"10.1016\/bs.vh.2015.11.002_bb0140","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0021-9258(17)33795-X","article-title":"Synthesis of 1\u03b1-hydroxy[6-3H]vitamin D3 and its metabolism to 1\u03b1,25-dihydroxy[6-3H]vitamin D3 in the rat","volume":"251","author":"Holick","year":"1976","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0145","first-page":"931","article-title":"Detection of vitamin D and its major metabolites","volume":"Vol. 2","author":"Hollis","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0006-2952(91)90160-7","article-title":"Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3","volume":"41","author":"Kissmeyer","year":"1991","journal-title":"Biochemical Pharmacology"},{"issue":"8","key":"10.1016\/bs.vh.2015.11.002_bb0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.31.8.973","article-title":"Disposition and metabolism of F6-1\u03b1,25(OH)2 vitamin D3 and 1\u03b1,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds","volume":"31","author":"Komuro","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/bs.vh.2015.11.002_bb0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2340\/0001555571475478","article-title":"Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study","volume":"71","author":"Kragballe","year":"1991","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1016\/bs.vh.2015.11.002_bb0165","first-page":"1525","article-title":"Development of OCT and ED-71","volume":"Vol. 2","author":"Kubodera","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0170","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1248\/cpb.34.2286","article-title":"Synthetic studies of vitamin D analogs. VII. Synthesis of 20-oxa-21-norvitamin D3 analogs","volume":"34","author":"Kubodera","year":"1986","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"10.1016\/bs.vh.2015.11.002_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcb.10346","article-title":"A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients","volume":"88","author":"Kubodera","year":"2003","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0039-128X(77)90056-3","article-title":"Synthesis of 1\u03b1-hydroxyergocalciferol","volume":"30","author":"Lam","year":"1977","journal-title":"Steroids"},{"key":"10.1016\/bs.vh.2015.11.002_bb0185","first-page":"1020","article-title":"How to define normal values for serum concentrations of 25-hydroxyvitamin D? An overview","volume":"Vol. 2","author":"Lips","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0190","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/ajkd.1998.v32.pm9808143","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D3","volume":"32","author":"Llach","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/bs.vh.2015.11.002_bb0195","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1\u03b1,25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.vh.2015.11.002_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0003-9861(85)90373-X","article-title":"Biological activities and binding properties of 23,23-difluoro-25-hydroxyvitamin D3 and its 1\u03b1-hydroxy derivative","volume":"241","author":"Nakada","year":"1985","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0205","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1021\/bi00605a021","article-title":"1\u03b1-Hydroxy-25-fluorovitamin D3: A potent analogue of 1\u03b1,25-dihydroxyvitamin D3","volume":"17","author":"Napoli","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0210","first-page":"1313","article-title":"Eldecalcitol for the treatment of osteoporosis","volume":"8","author":"Noguchi","year":"2013","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/bs.vh.2015.11.002_bb0215","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1248\/cpb.32.3525","article-title":"Synthesis and biological activity of 1\u03b1-fluoro-25-hydroxyvitamin D3","volume":"32","author":"Ohshima","year":"1984","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"10.1016\/bs.vh.2015.11.002_bb0220","first-page":"E159","article-title":"Biological activity of 24,24-difluoro-1,25-dihydroxyvitamin D3","volume":"244","author":"Okamoto","year":"1983","journal-title":"American Journal of Physiology"},{"key":"10.1016\/bs.vh.2015.11.002_bb0225","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","article-title":"Effects of 1-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis","volume":"54","author":"Orimo","year":"1994","journal-title":"Calcified Tissue International"},{"key":"10.1016\/bs.vh.2015.11.002_bb0230","first-page":"52","article-title":"Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3","volume":"47","author":"Orimo","year":"1987","journal-title":"Bone and Mineral"},{"key":"10.1016\/bs.vh.2015.11.002_bb0235","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/jo01304a022","article-title":"Direct (1) hydroxylation of vitamin D3 and related compounds","volume":"45","author":"Paaren","year":"1980","journal-title":"Journal of Organic Chemistry"},{"key":"10.1016\/bs.vh.2015.11.002_bb0240","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd3318","article-title":"Vitamin D, disease and therapeutic opportunities","volume":"9","author":"Plum","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.vh.2015.11.002_bb0255","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1016\/S0040-4039(01)94260-1","article-title":"The synthesis of 1\u03b1,25-dihydroxycholecalciferol\u2014A metabolically active form of vitamin D3","volume":"40","author":"Semmler","year":"1972","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/bs.vh.2015.11.002_bb0260","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s001980050214","article-title":"A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group","volume":"10","author":"Shiraki","year":"1999","journal-title":"Osteoporosis International"},{"key":"10.1016\/bs.vh.2015.11.002_bb0265","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jn\/114.11.2043","article-title":"Antirachitic activity of 1\u03b1-hydroxyergocalciferol and 1\u03b1-hydroxycholecalciferol in rat","volume":"114","author":"Sjoden","year":"1984","journal-title":"Journal of Nutrition"},{"key":"10.1016\/bs.vh.2015.11.002_bb0270","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/bs.vh.2015.11.002_bb9010","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2015.11.002_bb0275","first-page":"222","article-title":"Sites of action of 1,25(OH)2 vitamin D3 identified by thaw-mount autoradiography","author":"Stumpf","year":"1981"},{"key":"10.1016\/bs.vh.2015.11.002_bb0280","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.505004","article-title":"Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid","volume":"206","author":"Stumpf","year":"1979","journal-title":"Science"},{"key":"10.1016\/bs.vh.2015.11.002_bb0285","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0003-9861(84)90161-9","article-title":"26,26,26,27,27,27-Hexafluoro-1,25-dihydroxyvitamin D3: A highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3","volume":"229","author":"Tanaka","year":"1984","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0003-9861(83)90076-0","article-title":"Metabolism and binding properties of 24,24-difluoro-25-hydroxyvitamin D3","volume":"225","author":"Tanaka","year":"1983","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0295","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2015.11.002_bb0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.vh.2015.11.002_bb0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00296065","article-title":"A novel synthetic vitamin D analogue, 2\u03b2-(3-hydroxypropoxy)1\u03b1,25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats","volume":"54","author":"Tsurukami","year":"1994","journal-title":"Calcified Tissue International"},{"key":"10.1016\/bs.vh.2015.11.002_bb0310","first-page":"1511","article-title":"Gemini: The 1,25-dihydroxy vitamin D analogs with two side-chains","volume":"Vol. 2","author":"Uskokovic","year":"2005"},{"key":"10.1016\/bs.vh.2015.11.002_bb0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2012.04.001","article-title":"Where is the vitamin D receptor?","volume":"523","author":"Wang","year":"2012","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.vh.2015.11.002_bb0320","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jbmr.2081","article-title":"Identification of the vitamin D receptor in osteoblasts and chondrocytes but not osteoclasts in mouse bone","volume":"29","author":"Wang","year":"2014","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/bs.vh.2015.11.002_bb0325","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/en.2006-0403","article-title":"Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1\u03b1-hydroxylase and parathyroid hormone null alleles","volume":"147","author":"Xue","year":"2006","journal-title":"Endocrinology"}],"container-title":["Vitamins & Hormones","Vitamin D Hormone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672915000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672915000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:34:29Z","timestamp":1692182069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672915000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128048245"],"references-count":65,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2015.11.002","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}